Skip to main content Help with accessibility Skip to main navigation

March 2024 updates to the website

The website has now been updated following March's LSCMMG

The following guidelines have been added/updated:

Lipid Management Guideline for Secondary Prevention CVD - updated

Recurrent UTI prophylactic antibiotic pathway - update to follow

Azithromycin information sheet - update to follow pending amendments and ratification

The following medicines have been added/updated following the latest Clinical Effectiveness Group (CEG) / Commissioning Resource Group (CRG) meeting:

Tirzepatide - Type 2 Diabetes (NICE TA924)

The following Items will be updated and added to the website following the next Clinical Effectiveness Group (CEG) / Commissioning Resource Group (CRG) Meeting:

Sucralfate - RAG review for different preparations

Daridorexant - treating long-term insomnia (NICE TA922)

Targeted-release budesonide - treating primary IgA nephropathy (NICE TA937)

Triptorelin - treatment of precocious puberty